COVID-19

Resources and Information

The health and well-being of our patients, their loved ones, and the healthcare professionals providing care for them is our top priority, especially during these uncertain times.


COVID-19 is impacting all of our lives with changes coming almost daily. AstraZeneca is committed to providing updated information and resources related to COVID-19 and the management of cancer as they become available.

For Patients and Loved Ones


COVID-19 Information for Cancer Patients:

The public health organizations and institutions mentioned below have offered general guidance for cancer patients and their loved ones.

 

 

CLL/SLL/MCL and COVID-19:

Resources from Lymphoma Research Foundation

 

Resources from Leukemia and Lymphoma Society (LLS)

 

Resources from Chronic Lymphocytic Leukemia (CLL) Society

 

Bladder Cancer and COVID-19:

Resources from Bladder Cancer Advocacy Network

 

Ovarian Cancer and COVID-19:

Resources from Ovarian Cancer Research Alliance

 

Resources from SHARE

 

Neurofibromatosis type 1 (NF1) and COVID-19:

Resources from Children's Tumor Foundation

 

Activities and educational resources that you can enjoy from home.

 

 

AstraZeneca’s Support Services

AstraZeneca’s Support Services for you and your loved ones are available should you need them:

Connecting patients, loved ones, and healthcare professionals to the medicines and support they may need. 1-844-275-2360

Program designed to help qualifying patients who are having financial difficulty affording their medication. 1-800-292-6363

AstraZeneca Information Center

For additional information: 1-800-236-9933

For Healthcare Professionals


If you are a registered healthcare provider with questions about COVID-19 and AstraZeneca medications, please visit AstraZeneca’s medical information site: AZmedical.com

American Society of Clinical Oncology (ASCO):

 

Centers for Medicare and Medicaid Services (CMS):

 

National Comprehensive Cancer Network (NCCN):

 

Lancet Oncology:

 

Association for Molecular Pathology (AMP):

 

College of American Pathologists (CAP):

 

Loading......

Additional Resources


Lung Cancer Diagnosis Decline Toolkit

The COVID-19 pandemic has caused disruption across cancer care, including the declines in lung cancer diagnoses. As the leading cause of cancer death in the US, this impact on lung cancer is especially alarming. It’s important to remind everyone to continue seeking care during COVID-19 because, even in the face of a global pandemic, cancer won’t wait. To help raise awareness around the decline in lung cancer diagnoses and its impact on cancer care, AstraZeneca has developed a communications toolkit to spread awareness about the importance of continuing to seek care and keeping in close contact with health care professionals during the pandemic.

This toolkit includes: